|
Video: What is a Stock Split?
|
|
BioRestorative Therapies is a life sciences company focused on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult stem cells. Co.'s cell therapy candidate, BRTX-100, is a product formulated from autologous (or person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. Co. is developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue. Co. has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. According to our BioRestorative Therapies stock split history records, BioRestorative Therapies has had 0 splits. | |
|
BioRestorative Therapies (BRTX) has 0 splits in our BioRestorative Therapies stock split history database.
Looking at the BioRestorative Therapies stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioRestorative Therapies shares, starting with a $10,000 purchase of BRTX, presented on a split-history-adjusted basis factoring in the complete BioRestorative Therapies stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/06/2014 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$0.36 |
|
End price/share: |
$1.36 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
279.17% |
|
Average Annual Total Return: |
14.26% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$37,926.45 |
|
Years: |
10.00 |
|
|
|
|
|